DrugRisk Adds Latest Court Decision in NuvaRing Lawsuits
Denver, CO (PRWEB) August 02, 2013 -- The birth control safety center at DrugRisk.com is announcing updated news for women using the contraceptive NuvaRing. A federal judge recently denied attempts by the manufacturer to dismiss a lawsuit alleging NuvaRing caused blood clots, allowing the first trial to start in October*.
DrugRisk provides those using popular prescription drugs and medical devices with the latest safety alerts, recalls, studies and legal news. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.
Health experts have linked contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots**.
So far, 1,296 patients have filed a NuvaRing lawsuit alleging blood clots, an increase of 11% in recent months***. Cases have been consolidated in a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.
Now, the resource center has learned that U.S. District Judge Rodney Sippel, who is overseeing the litigation, recently denied a motion filed by Merck subsidiary Organon USA to dismiss the case of Marianne Prather alleging DVT and pulmonary embolism from the device*. The first trial for these lawsuits has been scheduled to start in October***.
Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Center or speak with a lawyer about their legal rights as soon as possible. DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*U.S. District Judge Rodney Sippel, 7/12/13; Case: 4:08-md-01964-RWS Doc. #: 1598
**New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840
***JPML 7/10/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-July-10-2013.pdf
Patient Advocate, DrugRisk, http://www.DrugRisk.com, 888-415-1859, [email protected]
Share this article